An NCI-designated Comprehensive Cancer Center
Monzr M. Al Malki, M.D.

Monzr M. Al Malki, M.D.

Hematologist - Oncologist
Clinical Expertise
  • Hematology and Hematopoietic Cell Transplantation
Assistant Clinical Professor, Department of Hematology and Hematopoietic Cell Transplantation
Other Languages Spoken
  • Arabic

Hematologist/oncologist Al Malki, M.D. joins City of Hope as Assistant Clinical Professor in the Department of Hematology and Hematopoietic Cell Transplantation. Dr. Al Malki graduated from the Damascus University School of Medicine (DUSM), Syria in 2003. He continued his education at Cleveland Clinic’s Huron Hospital, completing his internship and residency in internal medicine.  He then went on to earn two fellowships - the first in hematology and medical oncology at Boston University School of Medicine Program at Roger William Medical Center in Providence, RI, and the latter here at City of Hope in hematopoietic stem cell transplantation.

Board-certified in internal medicine, hematology and medical oncology, Dr. Al Malki holds memberships with several professional societies including the American College of Physicians, the American Society of Hematology and the American Society of Clinical Oncology.  He is also serving as an inspector-trainee for FACT (Foundation for the Accreditation of Cellular Therapy).

Dr. Al Malki has served as a postdoctoral research fellow at Massachusetts General Hospital and Harvard Medical School in Boston, MA. He has written several publications and has been invited to discuss his work at presentations and poster sessions.


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

Al-Malki MM, Castillo JJ, Sloan JM, Re A. Hematopoietic cell transplantation
for plasmablastic lymphoma: a review. Biol Blood Marrow Transplant. 2014
Dec;20(12):1877-84. doi: 10.1016/j.bbmt.2014.06.009. Epub 2014 Jun 16. Review.
PubMed PMID: 24946718.
Al-Homsi AS, Lai Z, Roy TS, Al-Malki MM, Kouttab N, Junghans RP. Post-transplant cyclophosphamide and bortezomib inhibit dendritic cell maturation and function and alter their IκB and NFκB. Transpl Immunol. 2014 Jan;30(1):40-5. doi: 10.1016/j.trim.2013.11.003. Epub 2013 Nov 19.
Jabbour M, Tuncer H, Castillo J, Butera J, Roy T, Pojani J, Al-Malki M,
Al-Homsi AS. Hematopoietic SCT for adult T-cell leukemia/lymphoma: a review. Bone
Marrow Transplant. 2011 Aug;46(8):1039-44. doi: 10.1038/bmt.2011.27. Epub 2011
Feb 28. Review. PubMed PMID: 21358685.
Osinbowale O, Al Malki M, Schade A, Bartholomew JR. An algorithm for managing
warfarin resistance. Cleve Clin J Med. 2009 Dec;76(12):724-30. doi:
10.3949/ccjm.76a.09062. Review. PubMed PMID: 19952297.
In The News
An Expert's Voice
Monzr M. Al Malki, M.D.

Half-matches open door to bone marrow transplant for more patients

Lester Wakefield, bone marrow transplant recipient, with his donor, Jonathan Bottom

'I wouldn't be here today': Bone marrow recipient reflects on the gift of life